The earnings call presented a positive outlook with significant revenue growth, profitability improvements, and membership expansion. Technological advancements and new product launches further underscore the company's strong position. However, the increased medical loss ratio and pressure from SEP membership additions provide challenges that need to be managed.

Company Guidance

In the third quarter earnings call for Oscar Health, the company reported robust financial performance, with revenue reaching $2.4 billion, marking a 68% increase year-over-year. The medical loss ratio rose by 80 basis points to 84.6%, while the adjusted EBITDA for the year-to-date was $312 million, an improvement of $246 million compared to the previous year. The company also reported a year-to-date profit of $179 million, reflecting a $300 million increase from last year. Oscar Health ended the quarter with 1.65 million members, a 68% increase year-over-year, and anticipates achieving total company adjusted EBITDA profitability this year. Looking ahead, Oscar aims for a 20% revenue CAGR and a 5% operating margin by 2027. The company has increased its total addressable market by 700,000 lives, now reaching approximately 11 million. Additionally, Oscar raised its full-year revenue guidance to $9.2 billion to $9.3 billion, attributing the increase to higher membership and favorable lapse rates. They expect the medical loss ratio to be at the high end of the previous range of 80.5% to 81.5%, and the SG&A expense ratio to improve to 19.4% to 19.6%.

Record Revenue Growth

Oscar Health reported a revenue of $2.4 billion for Q3 2024, a 68% increase year-over-year.

Significant Improvement in Profitability

The company achieved a year-to-date profit of $179 million, a $300 million improvement over the previous year.

Membership Growth

Oscar Health closed the first 9 months of 2024 with approximately 1.65 million members, a 68% increase year-over-year.

Technological Advancements

Oscar prototyped AI tools to prevent fraud and launched AI programs for providers to enhance member care speed.

Expansion and New Product Launches

Oscar expanded to new markets increasing total addressable lives to 11 million and introduced new health plans including a multi-condition plan and a tech-first HMO.

Improvement in SG&A Ratio

The third quarter SG&A expense ratio improved by approximately 360 basis points year-over-year to 19%.

---

Oscar Health (OSCR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OSCR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
May 13, 2021	2021 (Q1)	-0.53 / -0.98	-0.473	-107.19% (-0.51)	―	―
Aug 12, 2021	2021 (Q2)	-0.47 / -0.35	-0.2	-75.00% (-0.15)	―	―
Nov 10, 2021	2021 (Q3)	-0.73 / -1.02	-0.386	-164.25% (-0.63)	―	―
Feb 10, 2022	2021 (Q4)	-0.98 / -0.95	-1.22	22.13% (+0.27)	―	―
May 10, 2022	2022 (Q1)	-0.21 / -0.36	-0.98	63.27% (+0.62)	―	―
Aug 11, 2022	2022 (Q2)	-0.48 / -0.53	-0.35	-51.43% (-0.18)	―	―
Nov 08, 2022	2022 (Q3)	-0.72 / -0.91	-1.02	10.78% (+0.11)
Feb 09, 2023	2022 (Q4)	-1.14 / -1.05	-0.95	-10.53% (-0.10)
May 09, 2023	2023 (Q1)	-0.06 / -0.18	-0.36	50.00% (+0.18)	―
Aug 08, 2023	2023 (Q2)	-0.22 / -0.07	-0.53	86.79% (+0.46)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

OSCR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 07, 2024	$15.55	$13.64	-12.28%
Aug 07, 2024	$17.23	$16.70	-3.08%
May 07, 2024	$18.97	$19.77	+4.22%
Feb 07, 2024	$13.41	$16.68	+24.38%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---